Johnson & Johnson
Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About JNJ
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments.
JNJ Key Statistics
Stock Snapshot
As of today, Johnson & Johnson(JNJ) shares are valued at $218.40. The company's market cap stands at 525.3B, with a P/E ratio of 19.78 and a dividend yield of 2.4%.
On 2026-01-22, Johnson & Johnson(JNJ) stock traded between a low of $209.42 and a high of $218.75. Shares are currently priced at $218.40, which is +4.3% above the low and -0.2% below the high.
Johnson & Johnson(JNJ) shares are trading with a volume of 14.76M, against a daily average of 10.26M.
During the past year, Johnson & Johnson(JNJ) stock moved between $141.50 at its lowest and $220.11 at its peak.
During the past year, Johnson & Johnson(JNJ) stock moved between $141.50 at its lowest and $220.11 at its peak.
JNJ News
Key Points Johnson & Johnson has increased its dividend each year for over half a century. The company has a very healthy financial profile. It has excellent...
Key Points Johnson & Johnson signed a deal to avoid tariffs. Although it faces other threats, it can overcome them. The drugmaker is a great dividend payer....
Johnson & Johnson ((JNJ)) has held its Q4 earnings call. Read on for the main highlights of the call. Claim 50% Off TipRanks Premium Unlock hedge fund-level dat...
Analyst ratings
58%
of 24 ratingsMore JNJ News
Thousands of women suing Johnson & Johnson (NYSE:JNJ) over claims that its talc-based baby powder caused ovarian cancer cleared a key procedural hurdle after a...
In early trading on Thursday, shares of Travelers Companies topped the list of the day's best performing Dow Jones Industrial Average components, trading up 1.6...
AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX AD...
J&J slips despite cheery 2026 guidance Johnson & Johnson reported fourth-quarter sales that beat expectations and gave rosy guidance for 2026. The company sai...
Technology J&J's Guidance Wallops Views, But Boston Scientific, Medtronic Take A Toll Licensing Johnson & Johnson (JNJ) stock toppled early Wednesday after the...
Johnson & Johnson (NYSE:JNJ) on Wednesday reported a fourth-quarter 2025 adjusted earnings of $2.46 per share, up 20.6% year over year, beating the consensus of...
Johnson & Johnson now expects to bring in $100 billion in revenue in 2026. (Photo by Mario Tama/Getty Images) Johnson & Johnson had another strong quarter, dri...
